# Cost-Effectiveness Analysis of Regorafenib for Gastrointestinal Stromal Tumour (GIST) in Germany

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-analysis-of-regorafenib-for-gastrointestinal-stromal-tumour/

## Facts

| Field | Value |
| --- | --- |
| Author Names | David Tamoschus,K. Draexler,Jane Chang,Christopher Ngai,Matthew Madin-Warburton,A. Pitcher |
| Citations | 4 |
| DOI | 10.1007/s40261-017-0514-3 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2517937094 |
| PMID | 28361439 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Christopher Ngai](https://scholariq.org/researchers/christopher-ngai/)

## Paper journal

- [Clinical Drug Investigation](https://scholariq.org/journals/clinical-drug-investigation/)

## Paper primary topic

- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)

## Paper topics

- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Musculoskeletal synovial abnormalities and treatments](https://scholariq.org/topics/musculoskeletal-synovial-abnormalities-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.